Severe Congenital Protein C Deficiency: Practical Aspects of Management

Ravi Shah1, Patrick Ferreira2, Shelina Karmali1

  • 1Pediatric Hematology, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Insights

Subcutaneous protein C (PC) therapy effectively managed purpura fulminans in a child with congenital PC deficiency for over three years. Home-based SC PC replacement proved safe and successful, monitored by PC activity and D-dimer levels.

Area of Science:

  • Biochemistry
  • Hematology
  • Pediatric Thrombosis

Background:

  • Severe congenital protein C (PC) deficiency can lead to life-threatening purpura fulminans.
  • Effective long-term management strategies for pediatric PC deficiency are crucial.

Observation:

  • A child with purpura fulminans secondary to severe congenital PC deficiency was treated with subcutaneous (SC) protein C (PC).
  • Home therapy involved SC PC administration (80-120 IU/kg over 60-90 min every 48 hours) for over three years.
  • Treatment monitoring included trough PC chromogenic activity (target ≥15%) and D-dimer levels.

Findings:

  • SC PC home therapy was successful for over three years in maintaining clinical stability.
  • Discontinuation of enoxaparin did not alter the clinical course, suggesting PC replacement alone was sufficient.
  • A notable discrepancy was observed between clotting-based and chromogenic-based PC activity measurements.

Implications:

  • Subcutaneous protein C replacement is a viable and effective long-term home therapy for severe congenital PC deficiency in children.
  • This approach offers a practical alternative to intravenous administration, improving patient quality of life.
  • Further investigation into the discrepancy between different PC activity assays is warranted for accurate therapeutic monitoring.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
612
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
7
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
428
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595